Aurobindo Pharma gets USFDA nod for generic antifungal injection

The approval by the US Food & Drug Administration (USFDA) is for Posaconazole injection of 300 mg/16.7 mL (18 mg/mL), single-dose vial, Aurobindo Pharma said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4mh7uSK
via IFTTT